Clinical Trials
4 trialsNCT07559786 2026-04-30
A Multicenter, Randomized, Cohort, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT07309211 2025-12-30
Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT
The First Affiliated Hospital with Nanjing Medical University
Recruiting
NCT06911606 2025-04-04
Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)
Guangdong Provincial People's Hospital
Phase 2 Recruiting
NCT06371482 2024-06-17
Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)
Hebei Medical University Fourth Hospital
Phase 2 Recruiting